Science Bites: Cancer metastasis potentially stopped with nanorods, CAR-T therapy to treat leukaemia – MIMS General News (Hong Kong) (registration) (blog)
MIMS General News (Hong Kong) (registration) (blog) |
Science Bites: Cancer metastasis potentially stopped with nanorods, CAR–T therapy to treat leukaemia
MIMS General News (Hong Kong) (registration) (blog) When cancer metastasises in the body, treatment options quickly become limited. Now, scientists may have discovered the key to stopping this process – by cutting off the protrusions on cancer cells that help it spread. Mostafa El-Sayed, Julius Brown … |
|
New gene therapy improves insulin sensitivity and diabetes markers in mice
Diabetes.co.uk New research presented at the last American Heart Association’s Scientific Sessions suggests that a therapy called Urocortin 2 gene transfer raises insulin sensitivity in mice. Urocortin 2 (Ucn2), from the corticotropin releasing factor (CRF) family of … |
Above the Law |
The Fight To Claim A Cure
Above the Law The sick patient is infused with genetically modified T–cells, natural cancer killers, prompting an immune response that sometimes results in the body killing off the cancer on its own. While CAR-T therapy doesn’t work yet for all patients and all … |
JD Supra (press release) |
Broad Institute backs central Crispr patent licensing platform
Chemistry World (subscription) The Broad Institute in Cambridge, US, and its partners Harvard University, the Massachusetts Institute of Technology and The Rockefeller University have submitted 22 patents in response to a call to create a joint licensing pool for Crispr genome … A CRISPR patent pool – one step closer to reality?JD Supra (press release) |
Drug Target Review |
CNIC scientists find the key to improved cancer immunotherapy
Drug Target Review The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell – one circulating in the blood and the other resident in tissues – that can be reactivated with current immunotherapy … |
Drug Target Review |
CNIC scientists find the key to improved cancer immunotherapy
Drug Target Review The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell – one circulating in the blood and the other resident in tissues – that can be reactivated with current immunotherapy … |